Industry | 2016.01.21
Celltrion and Medidata Team Up to Transform Global Clinical Trials for Biosimilars
NEW YORK & SEOUL, Korea--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and Korean biopharmaceutical company Celltrion (KOSDAQ:068270) today announced that the Seoul-based organization has adopted Medidata\'s industry-leading technology platform. A global leader in biosimilars R&D, Celltrion will rely on the Medidata Clinical Cloud® to enhance the speed, efficiency and accuracy of its clinical trials. “Cel
For more information, please visit
http://www.businesswire.com/news/home/20[...]ansform-Global-Clinical-Trials
